Clinical trial
Cladribine Tablets: Observational Evaluation of Effectiveness and PROs in Suboptimally Controlled Patients Previously Taking Oral or Infusion DMDs for RMS (MASTER-2)
NCT03933202 is registered in ClinicalTrials.gov with EMD Serono Research & Development Institute, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cladribine Tablets: Observational Evaluation of Effectiveness and PROs in Suboptimally Controlled Patients Previously Taking Oral or Infusion DMDs for RMS (MASTER-2)
- Lead sponsor
- EMD Serono Research & Development Institute, Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 22, 2019
- Completion date
- November 11, 2024
- Enrollment
- 291 (actual)
- Sites
- 66
Conditions
As the registry lists them; a condition with its own page is linked.